Association of opioid use with response to immune checkpoint inhibitors.

被引:0
作者
Weinfeld, Michael
Wang, Heidy
Liu, Li C.
Pasquinelli, Mary
Huber, Michael
Feldman, Lawrence Eric
Weinberg, Frank
机构
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois, Sch Publ Hlth, Chicago, IL USA
[3] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
[4] Jesse Brown VA Med Ctr, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14595
引用
收藏
页数:1
相关论文
共 50 条
[31]   Strategies for the use of immune checkpoint inhibitors [J].
Noriomi Matsumura .
International Cancer Conference Journal, 2021, 10 :265-265
[32]   Strategies for the use of immune checkpoint inhibitors [J].
Matsumura, Noriomi .
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2021, 10 (04) :265-265
[33]   Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors. [J].
Morikawa, Ryo ;
Nitta, Kentaro ;
Yasuda, Shuntaro ;
Noji, Rika ;
Kano, Yoshihito ;
Sato, Shingo ;
Ikeda, Sadakatsu ;
Nagata, Masashi ;
Mori, Takehiko ;
Suenaga, Mitsukuni .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :791-791
[34]   Oral adverse events in cancer patients treated with immune checkpoint inhibitors. [J].
Xu, Yuanming ;
Sonis, Stephen T. ;
Wen, Natalie ;
Salous, Moaiad ;
Villa, Alessandro .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[35]   Mega- and meta-analyses of fecal metagenomic studies in predicting response to immune checkpoint inhibitors. [J].
Heirali, Alya ;
Chen, Bo ;
Wong, Matthew ;
Schneeberger, Pierre H. H. ;
Rey, Victor ;
Spreafico, Anna ;
Xu, Wei ;
Coburn, Bryan .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[36]   Predictors of immune-related adverse events associated with checkpoint inhibitors. [J].
Alsayed, Alhareth ;
Manne, Ashish ;
Escobar, Daisy E. ;
Sharma, Gaurav ;
Prodduturvar, Pranitha ;
Alkharabsheh, Omar .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[37]   Biomarkers to predict immune-related adverse events with checkpoint inhibitors. [J].
Head, Lia ;
Gorden, Nicholas ;
Van Gulick, Robert ;
Amato, Carol M. ;
Frazer-Abel, Ashley ;
Robinson, William ;
Holers, V. Michael ;
Messersmith, Wells A. ;
Davis, S. Lindsey .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
[38]   The risk factors of immune-mediated liver injury caused by immune checkpoint inhibitors. [J].
Wang, Yawen ;
Chen, Kefan ;
He, Junhao ;
Xu, Jing ;
Chen, Jie .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL) :e14587-e14587
[39]   Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors [J].
Chen, Yu ;
Li, Yi ;
Guan, Yanfang ;
Huang, Yingying ;
Lin, Jing ;
Chen, Lizhu ;
Li, Jin ;
Chen, Gang ;
Pan, Leong Kin ;
Xia, Xuefeng ;
Xu, Ning ;
Chang, Lianpeng ;
Guo, Zengqing ;
Pan, Jianji ;
Yi, Xin ;
Chen, Chuanben .
MOLECULAR ONCOLOGY, 2020, 14 (09) :2096-2110
[40]   Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma [J].
Scovell, Jason M. ;
Benz, Karl ;
Samarska, Iryna ;
Kohn, Taylor P. ;
Hooper, Jody E. ;
Matoso, Andres ;
Herati, Amin S. .
JAMA ONCOLOGY, 2020, 6 (08) :1297-1299